Literature DB >> 2032976

Effect of hemoglobin concentration on maximal O2 uptake in canine gastrocnemius muscle in situ.

M C Hogan1, D E Bebout, P D Wagner.   

Abstract

O2 delivery to maximally working muscle was decreased by altering hemoglobin (Hb) concentration and arterial PO2 (PaO2) to investigate whether the reductions in maximal O2 uptake (VO2max) that occur with lowered [Hb] are in part related to changes in the effective muscle O2 diffusing capacity (DmO2). Two sets of experiments were conducted. In the initial set (n = 8), three levels of Hb [5.8 +/- 0.3, 9.4 +/- 0.1, and 14.4 +/- 0.6 (SE) g/100 ml] in the blood were used in random order to pump perfuse, at equal muscle blood flows and PaO2, maximally working isolated dog gastrocnemius muscle. VO2max declined with decreasing [Hb], but the relationship between VO2max and both the effluent venous PO2 (PvO2) and the calculated mean capillary PO2 (PcO2) was not linear through the origin and, therefore, not compatible with a single value of DmO2 (as calculated by Bohr integration using a model based on Fick's law of diffusion). To clarify these results, a second set of experiments (n = 6) was conducted in which two levels of Hb (14.0 +/- 0.6 and 6.9 +/- 0.6 g/100 ml) were each combined with two levels of oxygenation (PaO2 79 +/- 8 and 29 +/- 2 Torr) and applied in random sequence to again pump perfuse maximally working dog gastrocnemius muscle at constant blood flow. In these experiments, the relationship between VO2max and both PvO2 and calculated PcO2 for each [Hb] was consistent with a constant estimate of DmO2 as PaO2 was reduced, but the calculated DmO2 for the lower [Hb] was 33% less than that at the higher [Hb] (P less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2032976     DOI: 10.1152/jappl.1991.70.3.1105

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  9 in total

1.  Human skeletal muscle intracellular oxygenation: the impact of ambient oxygen availability.

Authors:  Russell S Richardson; Sandrine Duteil; Claire Wary; D Walter Wray; Jan Hoff; Pierre G Carlier
Journal:  J Physiol       Date:  2006-01-05       Impact factor: 5.182

Review 2.  Maximal oxygen consumption in healthy humans: theories and facts.

Authors:  Guido Ferretti
Journal:  Eur J Appl Physiol       Date:  2014-07-02       Impact factor: 3.078

3.  Effects of erythropoietin on muscle O2 transport during exercise in patients with chronic renal failure.

Authors:  R M Marrades; J Roca; J M Campistol; O Diaz; J A Barberá; J V Torregrosa; J R Masclans; A Cobos; R Rodríguez-Roisin; P D Wagner
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

Review 4.  Oxygen transport in the microcirculation and its regulation.

Authors:  Roland N Pittman
Journal:  Microcirculation       Date:  2013-02       Impact factor: 2.628

5.  Determinants of the diminished exercise capacity in patients with chronic obstructive pulmonary disease: looking beyond the lungs.

Authors:  Ryan M Broxterman; Jan Hoff; Peter D Wagner; Russell S Richardson
Journal:  J Physiol       Date:  2020-01-19       Impact factor: 5.182

6.  Effect of blood haemoglobin concentration on V(O2,max) and cardiovascular function in lowlanders acclimatised to 5260 m.

Authors:  J A L Calbet; G Rådegran; R Boushel; H Søndergaard; B Saltin; P D Wagner
Journal:  J Physiol       Date:  2002-12-01       Impact factor: 5.182

7.  The effects of thermogenic agents on hindlimb oxygen consumption in the dog: ICI D7114 and noradrenaline.

Authors:  J L Gainer; M G Briscoe; B R Holloway
Journal:  Experientia       Date:  1993-01-15

Review 8.  Limitations of oxygen transport to the cell.

Authors:  P D Wagner
Journal:  Intensive Care Med       Date:  1995-05       Impact factor: 17.440

Review 9.  Erythropoietin and the use of a transgenic model of erythropoietin-deficient mice.

Authors:  Aurélien Pichon; Florine Jeton; Raja El Hasnaoui-Saadani; Luciana Hagström; Thierry Launay; Michèle Beaudry; Dominique Marchant; Patricia Quidu; Jose-Luis Macarlupu; Fabrice Favret; Jean-Paul Richalet; Nicolas Voituron
Journal:  Hypoxia (Auckl)       Date:  2016-04-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.